Safety and effectiveness of rituximab biosimilar (Rituximab-GP2013) versus originator in rheumatoid arthritis: real-world evidence from a single center.
- DOI
- 10.1016/j.clinsp.2026.101040
- Published
- 2026-07-28
- Container
- Clinics (Sao Paulo)
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.clinsp.2026.101040,
title = {Safety and effectiveness of rituximab biosimilar (Rituximab-GP2013) versus originator in rheumatoid arthritis: real-world evidence from a single center.},
author = {Bayeh B and Reyes-Neira F and Bonfiglioli KR and Aikawa NE and Assad APL and Miossi R and de Souza FHC and Insfran CE and Giardini HAM and Yuki EFN and Franco A and Domiciano DS and de Moraes JCB and Bonfa E and Saad CGS and de Medeiros-Ribeiro AC and Shimabuco AY.},
year = {2026},
journal = {Clinics (Sao Paulo)},
doi = {10.1016/j.clinsp.2026.101040},
url = {https://doi.org/10.1016/j.clinsp.2026.101040}
}RIS
TY - JOUR TI - Safety and effectiveness of rituximab biosimilar (Rituximab-GP2013) versus originator in rheumatoid arthritis: real-world evidence from a single center. AU - Bayeh B AU - Reyes-Neira F AU - Bonfiglioli KR AU - Aikawa NE AU - Assad APL AU - Miossi R AU - de Souza FHC AU - Insfran CE AU - Giardini HAM AU - Yuki EFN AU - Franco A AU - Domiciano DS AU - de Moraes JCB AU - Bonfa E AU - Saad CGS AU - de Medeiros-Ribeiro AC AU - Shimabuco AY. PY - 2026 JO - Clinics (Sao Paulo) DO - 10.1016/j.clinsp.2026.101040 UR - https://doi.org/10.1016/j.clinsp.2026.101040 ER -
APA
B, B., F, R., KR, B., NE, A., APL, A., R, M., FHC, D. S., CE, I., HAM, G., EFN, Y., A, F., DS, D., JCB, D. M., E, B., CGS, S., AC, D. M., & AY., S. (2026). Safety and effectiveness of rituximab biosimilar (Rituximab-GP2013) versus originator in rheumatoid arthritis: real-world evidence from a single center.. Clinics (Sao Paulo). https://doi.org/10.1016/j.clinsp.2026.101040
Source records
- europe-pmc · retrieved 2026-09-25T20:28:35.836Z